I do empathise with the holders of CTT, this fall in share price has shocked me. I am speaking as someone who owned the stock.
The company had a 1st Half NPAT of $4.7 million which has been wiped out in a quarter with a $(4.7 million) EBITDA loss.
Judging from the commentary provided, any profit in the final quarter would salvage what has been a harrowing year. April sales are shaky.
The P/S is attractive but only by itself. When you think of Cettire as a historically successful (profitable) company, it would take significant Q4 earnings for an attractive P/E. Say 5 million, and then on a market cap of 190 million you would have a P/E of under 40. Which can be seen as good for growth companies.
- Forums
- ASX - By Stock
- CTT
- Ann: Q3 FY25 Trading & Market Update
CTT
cettire limited
Add to My Watchlist
5.80%
!
36.5¢

Ann: Q3 FY25 Trading & Market Update, page-71
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
36.5¢ |
Change
0.020(5.80%) |
Mkt cap ! $139.1M |
Open | High | Low | Value | Volume |
34.5¢ | 37.5¢ | 34.5¢ | $3.364M | 9.250M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 313504 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 45549 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 145155 | 0.350 |
2 | 62500 | 0.345 |
4 | 35764 | 0.340 |
2 | 26432 | 0.335 |
1 | 2000 | 0.330 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 45549 | 2 |
0.370 | 13951 | 2 |
0.375 | 267987 | 4 |
0.380 | 79396 | 7 |
0.385 | 18000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
CTT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online